EUVIMEDEUVIMED entdecken
Open Access

Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting

Ousseny Zerbo iD, Joan Bartlett iD, Bruce Fireman, Ned Lewis, Kristin Goddard iD, Kathleen Dooling, Jonathan Duffy iD, Jason Glanz, Allison Naleway iD, James G Donahue, Nicola P Klein iD

Annals of Internal Medicine · 2024-02 · 177 (2) · 189-195

DOI: 10.7326/m23-2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Internal Medicine, 2024-02. Verfasst von Ousseny Zerbo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California (O.Z., J.B., B.F., N.L., K.G., N.P.K.). Hauptthemen laut MEDLINE: Herpes Zoster, Herpes Zoster Vaccine. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes ZosterHerpes Zoster VaccineHumansHerpesvirus 3, HumanProspective StudiesVaccinationVaccines, SyntheticMiddle AgedClinical Trials as Topic

Substanzen

Herpes Zoster VaccineVaccines, Synthetic

Autor:innen und Institutionen

  • Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California (O.Z., J.B., B.F., N.L., K.G., N.P.K.).
  • Centers for Disease Control and Prevention, Atlanta, Georgia (K.D., J.D.).
  • Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado (J.G.).
  • Kaiser Permanente Center for Health Research, Portland, Oregon (A.N.).
  • Marshfield Clinic Research Institute, Marshfield, Wisconsin (J.G.D.).

ORCID-Profile: Ousseny Zerbo, Joan Bartlett, Kristin Goddard, Jonathan Duffy, Allison Naleway, Nicola P Klein

Förderung

  • Intramural CDC HHS

Zitieren

APA

Zerbo, O., Bartlett, J., Fireman, B., Lewis, N., Goddard, K., Dooling, K., Duffy, J., Glanz, J., Naleway, A., Donahue, J. G., & Klein, N. P. (2024). Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting. Annals of Internal Medicine, 177(2), 189-195. https://doi.org/10.7326/m23-2023

Vancouver

Zerbo O, Bartlett J, Fireman B, Lewis N, Goddard K, Dooling K, et al. Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting. Annals of Internal Medicine. 2024;177(2):189-195. doi:10.7326/m23-2023

BibTeX
@article{Zerbo2024,
  author = {Zerbo, Ousseny and Bartlett, Joan and Fireman, Bruce and Lewis, Ned and Goddard, Kristin and Dooling, Kathleen and Duffy, Jonathan and Glanz, Jason and Naleway, Allison and Donahue, James G and Klein, Nicola P},
  title = {Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting},
  journal = {Annals of Internal Medicine},
  year = {2024},
  volume = {177},
  number = {2},
  pages = {189--195},
  doi = {10.7326/m23-2023}
}
Kostenlos starten →